— 
| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 250mg | 180 pill | NZD8.41 | NZD1,681.40 NZD1,513.26 Best Price Popular | |
| 250mg | 120 pill | NZD9.23 | NZD1,231.59 NZD1,108.43 | |
| 250mg | 90 pill | NZD10.17 | NZD1,017.40 NZD915.66 | |
| 250mg | 60 pill | NZD11.21 | NZD746.98 NZD672.28 | |
| 250mg | 30 pill | NZD12.84 | NZD428.36 NZD385.53 |
Ticlid, known generically as ticlopidine, is an antiplatelet medication commonly prescribed to help prevent blood clots. It’s often used in New Zealand for patients who have experienced strokes, transient ischemic attacks (TIAs), or are at high risk of clot-related events. Ticlid works by reducing the ability of platelets in the blood to stick together, thereby lowering the risk of clot formation that can lead to serious cardiovascular complications.
The medication inhibits a protein on the surface of platelets called the P2Y12 receptor. By blocking this receptor, Ticlid prevents platelets from aggregating, which is a crucial process in the formation of blood clots. This mechanism helps reduce the chances of blood clots forming in arteries and other blood vessels, making it an essential medication for certain at-risk populations in New Zealand.
Many patients report that Ticlid effectively reduces the risk of stroke and heart attack when taken consistently as prescribed. It is often used as an alternative for people who cannot tolerate aspirin or other antiplatelet drugs. While not suitable for everyone, Ticlid has shown significant benefits in preventing the recurrence of ischemic events, especially in patients with a previous history of stroke or TIA.
Like all medications, Ticlid may cause side effects. Some common issues include gastrointestinal discomfort, diarrhea, rash, or headache. More serious but less common side effects involve blood disorders such as neutropenia or thrombocytopenia, which require immediate medical attention. In New Zealand, regular blood tests areusually recommended to monitor for these adverse effects during treatment with Ticlid.
Before starting Ticlid, your healthcare provider will review your medical history. People with liver or kidney problems, bleeding disorders, or a history of blood issues need to be cautious. It’s also important to inform your doctor if you are taking other medications, such as blood thinners or NSAIDs, as interactions can occur. Due to its blood-thinning properties, Ticlid increases bleeding risks, so extra caution is needed during activities that might cause injury.
In New Zealand, Ticlid is available through licensed pharmacies with a prescription from a registered healthcare professional. It is crucial for patients to follow their doctor’s instructions carefully and attend regular check-ups to ensure safe and effective use. Online pharmacy services in New Zealand offer a convenient option for obtaining Ticlid, provided they comply with local regulations and require valid prescriptions.
Many users in New Zealand report a positive experience with Ticlid when used as part of a comprehensive treatment plan. Patients appreciate the added protection it offers against stroke recurrence. However, some note the importance of blood tests and monitoring to manage side effects. Overall, Ticlid remains a trusted choice for those at high risk of clot formation, especially when other antiplatelet options are not suitable.
Ticlid remains an important medication in the fight against blood clots in New Zealand. Its effectiveness, combined with proper medical supervision, can provide significant protection for at-risk patients. Always consult your healthcare provider before starting or stopping Ticlid, and ensure all recommended checks are completed during your treatment.
14–21 days. Free from NZD347.22 .
5–9 days. NZD52.08
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
